<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36189286</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.</ArticleTitle><Pagination><StartPage>952987</StartPage><MedlinePgn>952987</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">952987</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.952987</ELocationID><Abstract><AbstractText Label="BACKGROUND">The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global crisis. Although many people recover from COVID-19 infection, they are likely to develop persistent symptoms similar to those of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after discharge. Those constellations of symptoms persist for months after infection, called Long COVID, which may lead to considerable financial burden and healthcare challenges. However, the mechanisms underlying Long COVID and ME/CFS remain unclear.</AbstractText><AbstractText Label="METHODS">We collected the genes associated with Long COVID and ME/CFS in databases by restricted screening conditions and clinical sample datasets with limited filters. The common genes for Long COVID and ME/CFS were finally obtained by taking the intersection. We performed several advanced bioinformatics analyses based on common genes, including gene ontology and pathway enrichment analyses, protein-protein interaction (PPI) analysis, transcription factor (TF)-gene interaction network analysis, transcription factor-miRNA co-regulatory network analysis, and candidate drug analysis prediction.</AbstractText><AbstractText Label="RESULTS">We found nine common genes between Long COVID and ME/CFS and gained a piece of detailed information on their biological functions and signaling pathways through enrichment analysis. Five hub proteins (IL-6, IL-1B, CD8A, TP53, and CXCL8) were collected by the PPI network. The TF-gene and TF-miRNA coregulatory networks were demonstrated by NetworkAnalyst. In the end, 10 potential chemical compounds were predicted.</AbstractText><AbstractText Label="CONCLUSION">This study revealed common gene interaction networks of Long COVID and ME/CFS and predicted potential therapeutic drugs for clinical practice. Our findings help to identify the potential biological mechanism between Long COVID and ME/CFS. However, more laboratory and multicenter evidence is required to explore greater mechanistic insight before clinical application in the future.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Lv, Zhang, Cai, Huang, Zhan and Liu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Yongbiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Junxiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chushuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Shaofeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jianbo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049490" MajorTopicYN="N">Systems Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">bioinformatics analyses</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">protein&#x2013;protein interaction network</Keyword><Keyword MajorTopicYN="N">systems biology</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36189286</ArticleId><ArticleId IdType="pmc">PMC9524193</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.952987</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Organization WH . Who coronavirus (Covid-19) dashboard (2022). Available at: https://covid19.who.int/.</Citation></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (Covid-19): A review. JAMA (2020) 324(8):782&#x2013;93. doi:&#xa0;10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Bodinier B, Barclay W, Ward H, Cooke G, et al. . Variant-specific symptoms of covid-19 among 1,542,510 people in England. medRxiv (2022) 2022.05.21.22275368. doi:&#xa0;10.1101/2022.05.21.22275368</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.21.22275368</ArticleId><ArticleId IdType="pmc">PMC9651890</ArticleId><ArticleId IdType="pubmed">36369151</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. . Persistent symptoms following sars-Cov-2 infection in a random community sample of 508,707 people. medRxiv (2021) 13(1):1957. doi:&#xa0;10.1101/2021.06.28.21259452</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of covid-19 in patients discharged from hospital: A cohort study. Lancet (2021) 397(10270):220&#x2013;32. doi:&#xa0;10.1016/s0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic Encephalomyelitis/Chronic fatigue syndrome may help unravel the pathogenesis of postacute covid-19 syndrome. Trends Mol Med (2021) 27(9):895&#x2013;906. doi:&#xa0;10.1016/j.molmed.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>
Statistics OfN . Prevalence of ongoing symptoms following coronavirus (Covid-19) infection in the uk (2022). Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/6may2022.</Citation></Reference><Reference><Citation>
Statistics OfN . The prevalence of long covid symptoms and covid-19 complications (2020). Available at: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications.</Citation></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME, Hastie C, Roderick P, Yao G, et al. . Characteristics of long covid: Findings from a social media survey. medRxiv (2021) 2021.03.21.21253968. doi:&#xa0;10.1101/2021.03.21.21253968</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.21.21253968</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon L, Reeves WC. Factors influencing the diagnosis of chronic fatigue syndrome. Arch Internal Med (2004) 164(20):2241&#x2013;5. doi:&#xa0;10.1001/archinte.164.20.2241</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.164.20.2241</ArticleId><ArticleId IdType="pubmed">15534161</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue S. Board on the Health of Select P . Institute of M. The National Academies Collection: Reports Funded by National Institutes of Health Beyond myalgic Encephalomyelitis/Chronic fatigue syndrome: Redefining an illness. Washington (DC): National Academies Press; (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. . Myalgic Encephalomyelitis/Chronic fatigue syndrome: Essentials of diagnosis and management. Mayo Clinic Proc (2021) 96(11):2861&#x2013;78. doi:&#xa0;10.1016/j.mayocp.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Zoller T, Steinbeis F, et al. . Chronic covid-19 syndrome and chronic fatigue syndrome (Me/Cfs) following the first pandemic wave in Germany &#x2013; a first analysis of a prospective observational study. medRxiv (2021) 22(5):bbab115. doi:&#xa0;10.1101/2021.02.06.21249256</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.06.21249256</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Bateman L. Will covid-19 lead to myalgic Encephalomyelitis/Chronic fatigue syndrome? Front Med (2021) 7:606824. doi:&#xa0;10.3389/fmed.2020.606824</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links covid-19 and myalgic Encephalomyelitis/Chronic fatigue syndrome. Proc Natl Acad Sci U.S.A. (2021) 118(34):e2024358118. doi:&#xa0;10.1073/pnas.2024358118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jassas HK, Al-Hakeim HK, Maes M. Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to covid-19: A nomothetic network approach. J Affect Disord (2022) 297:233&#x2013;45. doi:&#xa0;10.1016/j.jad.2021.10.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.10.039</ArticleId><ArticleId IdType="pmc">PMC8541833</ArticleId><ArticleId IdType="pubmed">34699853</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. The road to addressing long covid. Science (2021) 373(6554):491&#x2013;3. doi:&#xa0;10.1126/science.abg7113</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg7113</ArticleId><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute covid-19 syndrome. Nat Med (2021) 27(4):601&#x2013;15. doi:&#xa0;10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-Moderate sars-Cov-2 infection. Nat Immunol (2022) 23(2):210&#x2013;6. doi:&#xa0;10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, Lee JN, et al. . Residual sars-Cov-2 viral antigens detected in gi and hepatic tissues from five recovered patients with covid-19. Gut (2022) 71(1):226&#x2013;9. doi:&#xa0;10.1136/gutjnl-2021-324280</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Advances in understanding the pathophysiology of chronic fatigue syndrome. Jama (2019) 322(6):499&#x2013;500. doi:&#xa0;10.1001/jama.2019.8312</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.8312</ArticleId><ArticleId IdType="pubmed">31276153</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariman AN, Vogelaers DP, Tobback E, Delesie LM, Hanoulle IP, Pevernagie DA. Sleep in the chronic fatigue syndrome. Sleep Med Rev (2013) 17(3):193&#x2013;9. doi:&#xa0;10.1016/j.smrv.2012.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2012.06.003</ArticleId><ArticleId IdType="pubmed">23046847</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller BA, Pryor JL, Giloteaux L. Inability of myalgic Encephalomyelitis/Chronic fatigue syndrome patients to reproduce Vo2Peak indicates functional impairment. J Transl Med (2014) 12:104. doi:&#xa0;10.1186/1479-5876-12-104</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-12-104</ArticleId><ArticleId IdType="pmc">PMC4004422</ArticleId><ArticleId IdType="pubmed">24755065</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med (2022) 28(5):911&#x2013;23. doi:&#xa0;10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y, Steinberg JG, Delliaux S. Chronic fatigue syndrome: Acute infection and history of physical activity affect resting levels and response to exercise of plasma Oxidant/Antioxidant status and heat shock proteins. J Intern Med (2012) 272(1):74&#x2013;84. doi:&#xa0;10.1111/j.1365-2796.2011.02488.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02488.x</ArticleId><ArticleId IdType="pubmed">22112145</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. . Diverse functional autoantibodies in patients with covid-19. Nature (2021) 595(7866):283&#x2013;8. doi:&#xa0;10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud SMH, Al-Mustanjid M, Akter F, Rahman MS, Ahmed K, Rahman MH, et al. . Bioinformatics and system biology approach to identify the influences of sars-Cov-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients. Briefings Bioinf (2021) 22(5):bbab115. doi:&#xa0;10.1093/bib/bbab115</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbab115</ArticleId><ArticleId IdType="pmc">PMC8083324</ArticleId><ArticleId IdType="pubmed">33847347</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kampen AHC, Moerland PD. Taking bioinformatics to systems medicine. In: Schmitz U, Wolkenhauer O, editors. Systems medicine. New York, NY: Humana Press; (2016). p. 17&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7120931</ArticleId><ArticleId IdType="pubmed">26677177</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, et al. . Comparative toxicogenomics database (Ctd): Update 2021. Nucleic Acids Res (2021) 49(D1):D1138&#x2013;d43. doi:&#xa0;10.1093/nar/gkaa891</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa891</ArticleId><ArticleId IdType="pmc">PMC7779006</ArticleId><ArticleId IdType="pubmed">33068428</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran M, Rosen N, Twik M, BarShir R, Stein TI, Dahary D, et al. . The genecards suite. In: Practical guide to life science databases. Springer Nature Singapore: Springer; (2021). p. 27&#x2013;56.</Citation></Reference><Reference><Citation>Pi&#xf1;ero J, Ram&#xed;rez-Anguita JM, Sa&#xfc;ch-Pitarch J, Ronzano F, Centeno E, Sanz F, et al. . The disgenet knowledge platform for disease genomics: 2019 update. Nucleic Acids Res (2019) 48(D1):D845&#x2013;D55. doi:&#xa0;10.1093/nar/gkz1021</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz1021</ArticleId><ArticleId IdType="pmc">PMC7145631</ArticleId><ArticleId IdType="pubmed">31680165</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. . Ncbi geo: Archive for functional genomics data sets&#x2013;update. Nucleic Acids Res (2013) 41(Database issue):D991&#x2013;5. doi:&#xa0;10.1093/nar/gks1193</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1193</ArticleId><ArticleId IdType="pmc">PMC3531084</ArticleId><ArticleId IdType="pubmed">23193258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, et al. . Long-term perturbation of the peripheral immune system months after sars-Cov-2 infection. BMC Med (2022) 20(1):26. doi:&#xa0;10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes A, Jacks A, Dahlman-Wright K, Evengard B, Wright FA, Pedersen NL, et al. . Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: No evidence of a biomarker. PloS One (2009) 4(6):e5805. doi:&#xa0;10.1371/journal.pone.0005805</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005805</ArticleId><ArticleId IdType="pmc">PMC2688030</ArticleId><ArticleId IdType="pubmed">19503787</ArticleId></ArticleIdList></Reference><Reference><Citation>Gow JW, Hagan S, Herzyk P, Cannon C, Behan PO, Chaudhuri A. A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics (2009) 2:38. doi:&#xa0;10.1186/1755-8794-2-38</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8794-2-38</ArticleId><ArticleId IdType="pmc">PMC2716361</ArticleId><ArticleId IdType="pubmed">19555476</ArticleId></ArticleIdList></Reference><Reference><Citation>Raijmakers RPH, Jansen AFM, Keijmel SP, Ter Horst R, Roerink ME, Novakovic B, et al. . A possible role for mitochondrial-derived peptides humanin and mots-c in patients with q fever fatigue syndrome and chronic fatigue syndrome. J Transl Med (2019) 17(1):157. doi:&#xa0;10.1186/s12967-019-1906-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1906-3</ArticleId><ArticleId IdType="pmc">PMC6518812</ArticleId><ArticleId IdType="pubmed">31088495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouquet J, Li T, Gardy JL, Kang X, Stevens S, Stevens J, et al. . Whole blood human transcriptome and virome analysis of Me/Cfs patients experiencing post-exertional malaise following cardiopulmonary exercise testing. PloS One (2019) 14(3):e0212193. doi:&#xa0;10.1371/journal.pone.0212193</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0212193</ArticleId><ArticleId IdType="pmc">PMC6428308</ArticleId><ArticleId IdType="pubmed">30897114</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for rna-seq data with Deseq2. Genome Biol (2014) 15(12):550. doi:&#xa0;10.1186/s13059-014-0550-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. . Limma powers differential expression analyses for rna-sequencing and microarray studies. Nucleic Acids Res (2015) 43(7):e47. doi:&#xa0;10.1093/nar/gkv007</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. . Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res (2016) 44(W1):W90&#x2013;7. doi:&#xa0;10.1093/nar/gkw377</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. . Gene ontology: Tool for the unification of biology. the gene ontology consortium. Nat Genet (2000) 25(1):25&#x2013;9. doi:&#xa0;10.1038/75556</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/75556</ArticleId><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium GO . The gene ontology resource: Enriching a gold mine. Nucleic Acids Res (2021) 49(D1):D325&#x2013;d34. doi:&#xa0;10.1093/nar/gkaa1113</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1113</ArticleId><ArticleId IdType="pmc">PMC7779012</ArticleId><ArticleId IdType="pubmed">33290552</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. Kegg: Integrating viruses and cellular organisms. Nucleic Acids Res (2020) 49(D1):D545&#x2013;D51. doi:&#xa0;10.1093/nar/gkaa970</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa970</ArticleId><ArticleId IdType="pmc">PMC7779016</ArticleId><ArticleId IdType="pubmed">33125081</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens M, Ammar A, Riutta A, Waagmeester A, Slenter DN, Hanspers K, et al. . Wikipathways: Connecting communities. Nucleic Acids Res (2021) 49(D1):D613&#x2013;d21. doi:&#xa0;10.1093/nar/gkaa1024</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1024</ArticleId><ArticleId IdType="pmc">PMC7779061</ArticleId><ArticleId IdType="pubmed">33211851</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, et al. . The reactome pathway knowledgebase. Nucleic Acids Res (2020) 48(D1):D498&#x2013;d503. doi:&#xa0;10.1093/nar/gkz1031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz1031</ArticleId><ArticleId IdType="pmc">PMC7145712</ArticleId><ArticleId IdType="pubmed">31691815</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura D. Biocarta. Biotech Softw Internet Rep (2001) 2:117&#x2013;20. doi: 10.1089/152791601750294344</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/152791601750294344</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. . The string database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded Gene/Measurement sets. Nucleic Acids Res (2021) 49(D1):D605&#x2013;d12. doi:&#xa0;10.1093/nar/gkaa1074</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. . Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 13(11):2498&#x2013;504. doi:&#xa0;10.1101/gr.1239303</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, et al. . Integration of biological networks and gene expression data using cytoscape. Nat Protoc (2007) 2(10):2366&#x2013;82. doi:&#xa0;10.1038/nprot.2007.324</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.324</ArticleId><ArticleId IdType="pmc">PMC3685583</ArticleId><ArticleId IdType="pubmed">17947979</ArticleId></ArticleIdList></Reference><Reference><Citation>Otasek D, Morris JH, Bou&#xe7;as J, Pico AR, Demchak B. Cytoscape automation: Empowering workflow-based network analysis. Genome Biol (2019) 20(1):185. doi:&#xa0;10.1186/s13059-019-1758-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-019-1758-4</ArticleId><ArticleId IdType="pmc">PMC6717989</ArticleId><ArticleId IdType="pubmed">31477170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. Cytohubba: Identifying hub objects and Sub-networks from complex interactome. BMC Syst Biol (2014) 8 Suppl 4(Suppl 4):S11. doi:&#xa0;10.1186/1752-0509-8-s4-s11</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-8-s4-s11</ArticleId><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. Networkanalyst 3.0: A visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res (2019) 47(W1):W234&#x2013;w41. doi:&#xa0;10.1093/nar/gkz240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz240</ArticleId><ArticleId IdType="pmc">PMC6602507</ArticleId><ArticleId IdType="pubmed">30931480</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza N. The encode project. Nat Methods (2012) 9(11):1046&#x2013;. doi:&#xa0;10.1038/nmeth.2238</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2238</ArticleId><ArticleId IdType="pubmed">23281567</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis CA, Hitz BC, Sloan CA, Chan ET, Davidson JM, Gabdank I, et al. . The encyclopedia of DNA elements (Encode): Data portal update. Nucleic Acids Res (2018) 46(D1):D794&#x2013;d801. doi:&#xa0;10.1093/nar/gkx1081</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1081</ArticleId><ArticleId IdType="pmc">PMC5753278</ArticleId><ArticleId IdType="pubmed">29126249</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 489(7414):57&#x2013;74. doi:&#xa0;10.1038/nature11247</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11247</ArticleId><ArticleId IdType="pmc">PMC3439153</ArticleId><ArticleId IdType="pubmed">22955616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel DP. Micrornas: Genomics, biogenesis, mechanism, and function. Cell (2004) 116(2):281&#x2013;97. doi:&#xa0;10.1016/s0092-8674(04)00045-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(04)00045-5</ArticleId><ArticleId IdType="pubmed">14744438</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobert O. Common logic of transcription factor and microrna action. Trends Biochem Sci (2004) 29(9):462&#x2013;8. doi:&#xa0;10.1016/j.tibs.2004.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2004.07.001</ArticleId><ArticleId IdType="pubmed">15337119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaborowski AB, Walther D. Determinants of correlated expression of transcription factors and their target genes. Nucleic Acids Res (2020) 48(20):11347&#x2013;69. doi:&#xa0;10.1093/nar/gkaa927</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa927</ArticleId><ArticleId IdType="pmc">PMC7672440</ArticleId><ArticleId IdType="pubmed">33104784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Ferguson J, Chang JT, Kluger Y. Inter- and intra-combinatorial regulation by transcription factors and micrornas. BMC Genomics (2007) 8:396. doi:&#xa0;10.1186/1471-2164-8-396</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-8-396</ArticleId><ArticleId IdType="pmc">PMC2206040</ArticleId><ArticleId IdType="pubmed">17971223</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwama H, Murao K, Imachi H, Ishida T. Microrna networks alter to conform to transcription factor networks adding redundancy and reducing the repertoire of target genes for coordinated regulation. Mol Biol Evol (2011) 28(1):639&#x2013;46. doi:&#xa0;10.1093/molbev/msq231</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msq231</ArticleId><ArticleId IdType="pubmed">20805189</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZP, Wu C, Miao H, Wu H. Regnetwork: An integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse. Database (Oxford) (2015) 2015:bav095. doi:&#xa0;10.1093/database/bav095</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/bav095</ArticleId><ArticleId IdType="pmc">PMC4589691</ArticleId><ArticleId IdType="pubmed">26424082</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, et al. . Dsigdb: Drug signatures database for gene set analysis. Bioinformatics (2015) 31(18):3069&#x2013;71. doi:&#xa0;10.1093/bioinformatics/btv313</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv313</ArticleId><ArticleId IdType="pmc">PMC4668778</ArticleId><ArticleId IdType="pubmed">25990557</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Group ftGAC-P-ACS . Persistent symptoms in patients after acute covid-19. JAMA (2020) 324(6):603&#x2013;5. doi:&#xa0;10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. . Post-discharge persistent symptoms and health-related quality of life after hospitalization for covid-19. J Infect (2020) 81(6):e4&#x2013;6. doi:&#xa0;10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long covid in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine (2021) 38:101019. doi:&#xa0;10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. . Long covid in a prospective cohort of home-isolated patients. Nat Med (2021) 27(9):1607&#x2013;13. doi:&#xa0;10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of covid-19. Science (2022) 375(6578):267&#x2013;9. doi:&#xa0;10.1126/science.abm2052</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>White P. Long covid: Don't consign Me/Cfs to history. Nature (2020) 587(7833):197. doi:&#xa0;10.1038/d41586-020-03136-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-03136-0</ArticleId><ArticleId IdType="pubmed">33173222</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbaraman N. Us health agency will invest $1 billion to investigate 'Long covid'. Nature (2021) 591(7850):356. doi:&#xa0;10.1038/d41586-021-00586-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00586-y</ArticleId><ArticleId IdType="pubmed">33664445</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt J, Blease C, Geraghty KJ. Long covid at the crossroads: Comparisons and lessons from the treatment of patients with myalgic Encephalomyelitis/Chronic fatigue syndrome (Me/Cfs). J Health Psychol (2022) 13591053221084494. doi:&#xa0;10.1177/13591053221084494</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13591053221084494</ArticleId><ArticleId IdType="pubmed">35341334</ArticleId></ArticleIdList></Reference><Reference><Citation>Routen A, O&#x2019;Mahoney L, Ayoubkhani D, Banerjee A, Brightling C, Calvert M, et al. . Understanding and tracking the impact of long covid in the united kingdom. Nat Med (2022) 28(1):11&#x2013;5. doi:&#xa0;10.1038/s41591-021-01591-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01591-4</ArticleId><ArticleId IdType="pubmed">34811549</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A. Long covid: New wine in need of new bottles. BMJ (2021) 375:n2736. doi:&#xa0;10.1136/bmj.n2736</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2736</ArticleId><ArticleId IdType="pubmed">34753712</ArticleId></ArticleIdList></Reference><Reference><Citation>Research NIfHaC . .</Citation></Reference><Reference><Citation>Meisel SR, Shapiro H, Radnay J, Neuman Y, Khaskia AR, Gruener N, et al. . Increased expression of neutrophil and monocyte adhesion molecules lfa-1 and mac-1 and their ligand icam-1 and vla-4 throughout the acute phase of myocardial infarction: Possible implications for leukocyte aggregation and microvascular plugging. J Am Coll Cardiol (1998) 31(1):120&#x2013;5. doi:&#xa0;10.1016/s0735-1097(97)00424-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0735-1097(97)00424-5</ArticleId><ArticleId IdType="pubmed">9426029</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with covid-19: An autopsy series from new Orleans. Lancet Respir Med (2020) 8(7):681&#x2013;6. doi:&#xa0;10.1016/s2213-2600(20)30243-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(20)30243-5</ArticleId><ArticleId IdType="pmc">PMC7255143</ArticleId><ArticleId IdType="pubmed">32473124</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, et al. . Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem (1992) 267(21):14998&#x2013;5004. doi: 10.1016/S0021-9258(18)42138-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)42138-2</ArticleId><ArticleId IdType="pubmed">1378843</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierhaus A, Ritz E, Nawroth PP. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease. Nephrol Dial Transplant (1996) 11 Suppl 5:87&#x2013;90. doi:&#xa0;10.1093/ndt/11.supp5.87</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/11.supp5.87</ArticleId><ArticleId IdType="pubmed">9044315</ArticleId></ArticleIdList></Reference><Reference><Citation>Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-McIntosh RP, et al. . Advanced glycation end products and their receptors Co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia (1997) 40(6):619&#x2013;28. doi:&#xa0;10.1007/s001250050725</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001250050725</ArticleId><ArticleId IdType="pubmed">9222639</ArticleId></ArticleIdList></Reference><Reference><Citation>Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes. Cardiovasc Res (2004) 63(4):582&#x2013;92. doi:&#xa0;10.1016/j.cardiores.2004.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2004.05.001</ArticleId><ArticleId IdType="pubmed">15306213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajikawa M, Nakashima A, Fujimura N, Maruhashi T, Iwamoto Y, Iwamoto A, et al. . Ratio of serum levels of ages to soluble form of rage is a predictor of endothelial function. Diabetes Care (2015) 38(1):119&#x2013;25. doi:&#xa0;10.2337/dc14-1435</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc14-1435</ArticleId><ArticleId IdType="pubmed">25336748</ArticleId></ArticleIdList></Reference><Reference><Citation>Heier M, Margeirsdottir HD, Gaarder M, Stens&#xe6;th KH, Brunborg C, Torjesen PA, et al. . Soluble rage and atherosclerosis in youth with type 1 diabetes: A 5-year follow-up study. Cardiovasc Diabetol (2015) 14:126. doi:&#xa0;10.1186/s12933-015-0292-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0292-2</ArticleId><ArticleId IdType="pmc">PMC4582642</ArticleId><ArticleId IdType="pubmed">26408307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagris M, Theofilis P, Antonopoulos AS, Tsioufis C, Oikonomou E, Antoniades C, et al. . Inflammatory mechanisms in covid-19 and atherosclerosis: Current pharmaceutical perspectives. Int J Mol Sci (2021) 22(12):6607. doi:&#xa0;10.3390/ijms22126607</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22126607</ArticleId><ArticleId IdType="pmc">PMC8234423</ArticleId><ArticleId IdType="pubmed">34205487</ArticleId></ArticleIdList></Reference><Reference><Citation>Erener S. Diabetes, infection risk and covid-19. Mol Metab (2020) 39:101044. doi:&#xa0;10.1016/j.molmet.2020.101044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2020.101044</ArticleId><ArticleId IdType="pmc">PMC7308743</ArticleId><ArticleId IdType="pubmed">32585364</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappalupi S, Salvadori L, Vukasinovic A, Donato R, Sorci G, Riuzzi F. Targeting rage to prevent sars-Cov-2-Mediated multiple organ failure: Hypotheses and perspectives. Life Sci (2021) 272:119251. doi:&#xa0;10.1016/j.lfs.2021.119251</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119251</ArticleId><ArticleId IdType="pmc">PMC7900755</ArticleId><ArticleId IdType="pubmed">33636175</ArticleId></ArticleIdList></Reference><Reference><Citation>Conca W, Alabdely M, Albaiz F, Foster MW, Alamri M, Alkaff M, et al. . Serum &#x3b2;2-microglobulin levels in coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity? PloS One (2021) 16(3):e0247758. doi:&#xa0;10.1371/journal.pone.0247758</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247758</ArticleId><ArticleId IdType="pmc">PMC7920360</ArticleId><ArticleId IdType="pubmed">33647017</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacha O, Sallman MA, Evans SE. Covid-19: A case for inhibiting il-17? Nat Rev Immunol (2020) 20(6):345&#x2013;6. doi:&#xa0;10.1038/s41577-020-0328-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0328-z</ArticleId><ArticleId IdType="pmc">PMC7194244</ArticleId><ArticleId IdType="pubmed">32358580</ArticleId></ArticleIdList></Reference><Reference><Citation>Raucci F, Mansour AA, Casillo GM, Saviano A, Caso F, Scarpa R, et al. . Interleukin-17a (Il-17a), a key molecule of innate and adaptive immunity, and its potential involvement in covid-19-Related thrombotic and vascular mechanisms. Autoimmun Rev (2020) 19(7):102572. doi:&#xa0;10.1016/j.autrev.2020.102572</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102572</ArticleId><ArticleId IdType="pmc">PMC7252120</ArticleId><ArticleId IdType="pubmed">32376393</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo MLV, Zanchettin AC, Vaz de Paula CB, Motta J&#xfa;nior JDS, Malaquias MAS, Raboni SM, et al. . Lung neutrophilic recruitment and il-8/Il-17a tissue expression in covid-19. Front Immunol (2021) 12:656350. doi:&#xa0;10.3389/fimmu.2021.656350</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656350</ArticleId><ArticleId IdType="pmc">PMC8044579</ArticleId><ArticleId IdType="pubmed">33868301</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong B, Huang L, He Y, Xie W, Yin Y, Shi Y, et al. . A genetic variant in il-6 lowering its expression is protective for critical patients with covid-19. Signal Transduct Target Ther (2022) 7(1):112. doi:&#xa0;10.1038/s41392-022-00923-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00923-1</ArticleId><ArticleId IdType="pmc">PMC8976167</ArticleId><ArticleId IdType="pubmed">35368020</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan R, Zhang Q, Anthony SM, Zhou Y, Zou X, Cassell M, et al. . Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the cns. Proc Natl Acad Sci USA (2020) 117(27):15902&#x2013;10. doi:&#xa0;10.1073/pnas.2003432117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003432117</ArticleId><ArticleId IdType="pmc">PMC7355048</ArticleId><ArticleId IdType="pubmed">32571951</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, et al. . Neuroinflammation in patients with chronic fatigue Syndrome/Myalgic encephalomyelitis: An &#xb9;&#xb9;c-(R)-Pk11195 pet study. J Nucl Med (2014) 55(6):945&#x2013;50. doi:&#xa0;10.2967/jnumed.113.131045</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.113.131045</ArticleId><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kistner TM, Pedersen BK, Lieberman DE. Interleukin 6 as an energy allocator in muscle tissue. Nat Metab (2022) 4(2):170&#x2013;9. doi:&#xa0;10.1038/s42255-022-00538-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-022-00538-4</ArticleId><ArticleId IdType="pubmed">35210610</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. . Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA (2016) 113(37):E5472&#x2013;80. doi:&#xa0;10.1073/pnas.1607571113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607571113</ArticleId><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo JC, Cordobilla B, Ferrer R, Giralt M, Alegre-Mart&#xed;n J, Castro-Marrero J. Are circulating fibroblast growth factor 21 and n-terminal prohormone of brain natriuretic peptide promising novel biomarkers in myalgic Encephalomyelitis/Chronic fatigue syndrome? Antioxid Redox Signal (2021) 34(18):1420&#x2013;7. doi:&#xa0;10.1089/ars.2020.8230</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2020.8230</ArticleId><ArticleId IdType="pubmed">33353469</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarski M, Freitag H, Lorenz S, Becker SC, Sotzny F, Bauer S, et al. . Delineating the association between soluble Cd26 and autoantibodies against G-protein coupled receptors, immunological and cardiovascular parameters identifies distinct patterns in post-infectious vs. non-Infection-Triggered myalgic Encephalomyelitis/Chronic fatigue syndrome. Front Immunol (2021) 12:644548. doi:&#xa0;10.3389/fimmu.2021.644548</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.644548</ArticleId><ArticleId IdType="pmc">PMC8056217</ArticleId><ArticleId IdType="pubmed">33889154</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenouillet E, Vigouroux A, Steinberg JG, Chagvardieff A, Retornaz F, Guieu R, et al. . Association of biomarkers with health-related quality of life and history of stressors in myalgic Encephalomyelitis/Chronic fatigue syndrome patients. J Transl Med (2016) 14(1):251. doi:&#xa0;10.1186/s12967-016-1010-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-016-1010-x</ArticleId><ArticleId IdType="pmc">PMC5006431</ArticleId><ArticleId IdType="pubmed">27580693</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantu N, Vyavahare S, Kumar S, Chen J, Kolhe R, Isales CM, et al. . Synergistic effects of multiple factors involved in covid-19-Dependent muscle loss. Aging Dis (2022) 13(2):344&#x2013;52. doi:&#xa0;10.14336/ad.2021.0817</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/ad.2021.0817</ArticleId><ArticleId IdType="pmc">PMC8947833</ArticleId><ArticleId IdType="pubmed">35371610</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell CD, Valanciute A, Gachanja NN, Stephen J, Penrice-Randal R, Armstrong SD, et al. . Tissue proteomic analysis identifies mechanisms and stages of immunopathology in fatal covid-19. Am J Respir Cell Mol Biol (2022) 66(2):196&#x2013;205. doi:&#xa0;10.1165/rcmb.2021-0358OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2021-0358OC</ArticleId><ArticleId IdType="pmc">PMC8845132</ArticleId><ArticleId IdType="pubmed">34710339</ArticleId></ArticleIdList></Reference><Reference><Citation>Harford JB, Kim SS, Pirollo KF, Chang EH. Tp53 gene therapy as a potential treatment for patients with covid-19. Viruses (2022) 14(4):739. doi:&#xa0;10.3390/v14040739</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040739</ArticleId><ArticleId IdType="pmc">PMC9027273</ArticleId><ArticleId IdType="pubmed">35458469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesmez Can F, &#xd6;zkurt Z, &#xd6;zt&#xfc;rk N, Sezen S. Effect of il-6, il-8/Cxcl8, ip-10/Cxcl 10 levels on the severity in covid 19 infection. Int J Clin Pract (2021) 75(12):e14970. doi:&#xa0;10.1111/ijcp.14970</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14970</ArticleId><ArticleId IdType="pmc">PMC8646602</ArticleId><ArticleId IdType="pubmed">34626520</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med (2009) 7:96. doi:&#xa0;10.1186/1479-5876-7-96</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-7-96</ArticleId><ArticleId IdType="pmc">PMC2779802</ArticleId><ArticleId IdType="pubmed">19909538</ArticleId></ArticleIdList></Reference><Reference><Citation>Urano T, Suzuki Y, Iwaki T, Sano H, Honkura N, Castellino FJ. Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis. Curr Drug Targets (2019) 20(16):1695&#x2013;701. doi:&#xa0;10.2174/1389450120666190715102510</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450120666190715102510</ArticleId><ArticleId IdType="pmc">PMC7696651</ArticleId><ArticleId IdType="pubmed">31309890</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. . Endotheliopathy in covid-19-Associated coagulopathy: Evidence from a single-centre, cross-sectional study. Lancet Haematol (2020) 7(8):e575&#x2013;e82. doi:&#xa0;10.1016/s2352-3026(20)30216-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh TJ, Bryer SC, Pucci AM, Sisson TH. Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. Am J Physiol Cell Physiol (2005) 289(1):C217&#x2013;23. doi:&#xa0;10.1152/ajpcell.00555.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00555.2004</ArticleId><ArticleId IdType="pubmed">15716324</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HM, Kuang S, Xiong X, Gao T, Liu C, Guo AY. Transcription factor and microrna Co-regulatory loops: Important regulatory motifs in biological processes and diseases. Brief Bioinform (2015) 16(1):45&#x2013;58. doi:&#xa0;10.1093/bib/bbt085</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbt085</ArticleId><ArticleId IdType="pubmed">24307685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JG, Simpson LJ, Ferreira AM, Rustagi A, Roque J, Asuni A, et al. . Cytokine profile in plasma of severe covid-19 does not differ from Ards and sepsis. JCI Insight (2020) 5(17):e140289. doi:&#xa0;10.1172/jci.insight.140289</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140289</ArticleId><ArticleId IdType="pmc">PMC7526438</ArticleId><ArticleId IdType="pubmed">32706339</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorgham K, Quentric P, G&#xf6;kkaya M, Marot S, Parizot C, Sauce D, et al. . Distinct cytokine profiles associated with covid-19 severity and mortality. J Allergy Clin Immunol (2021) 147(6):2098&#x2013;107. doi:&#xa0;10.1016/j.jaci.2021.03.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.03.047</ArticleId><ArticleId IdType="pmc">PMC8061091</ArticleId><ArticleId IdType="pubmed">33894209</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell L, Broderick G, Taylor R, Fernandes H, Harvey J, Barnes Z, et al. . Illness progression in chronic fatigue syndrome: A shifting immune baseline. BMC Immunol (2016) 17:3. doi:&#xa0;10.1186/s12865-016-0142-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12865-016-0142-3</ArticleId><ArticleId IdType="pmc">PMC4785654</ArticleId><ArticleId IdType="pubmed">26965484</ArticleId></ArticleIdList></Reference><Reference><Citation>Cammaerts S, Strazisar M, Smets B, Weckhuysen S, Nordin A, De Jonghe P, et al. . Schizophrenia-associated Mir204 regulates noncoding rnas and affects neurotransmitter and ion channel gene sets. PloS One (2015) 10(12):e0144428. doi:&#xa0;10.1371/journal.pone.0144428</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0144428</ArticleId><ArticleId IdType="pmc">PMC4695081</ArticleId><ArticleId IdType="pubmed">26714269</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaar D, Goodell L, Aisner J, Cui XX, Han ZT, Chang R, et al. . A phase I clinical trial of 12- O-Tetradecanoylphorbol-13-Acetate for patients with Relapsed/Refractory malignancies. Cancer Chemother Pharmacol (2006) 57(6):789&#x2013;95. doi:&#xa0;10.1007/s00280-005-0125-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00280-005-0125-1</ArticleId><ArticleId IdType="pubmed">16231182</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreakos E, Papadaki M, Serhan CN. Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in covid-19. Allergy (2021) 76(3):626&#x2013;8. doi:&#xa0;10.1111/all.14595</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14595</ArticleId><ArticleId IdType="pmc">PMC7537007</ArticleId><ArticleId IdType="pubmed">32956495</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos A, Ebrecht M, Roberts AD, Poon L, Rohleder N, Cleare AJ. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test. J Affect Disord (2009) 112(1-3):289&#x2013;94. doi:&#xa0;10.1016/j.jad.2008.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2008.05.001</ArticleId><ArticleId IdType="pubmed">18573538</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Alvarez S, Solesio ME, Manzanares J, Jord&#xe1;n J, Galindo MF. Lactacystin requires reactive oxygen species and bax redistribution to induce mitochondria-mediated cell death. Br J Pharmacol (2009) 158(4):1121&#x2013;30. doi:&#xa0;10.1111/j.1476-5381.2009.00388.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2009.00388.x</ArticleId><ArticleId IdType="pmc">PMC2785533</ArticleId><ArticleId IdType="pubmed">19785649</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Stubbs B, K&#xf6;hler CA, Walder K, Slyepchenko A, Berk M, et al. . The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep Med Rev (2018) 41:255&#x2013;65. doi:&#xa0;10.1016/j.smrv.2018.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2018.03.007</ArticleId><ArticleId IdType="pubmed">29759891</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>